Fredun Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts

Fredun Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter
All Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Fredun Pharmaceuticals Ltd.
20 May 2022
653.80
1.35%
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
This is to inform you that pursuant to Regulation 30(6) of the SEBI (Listing and Disclosure Requirements), 2015, the Analyst Meet was held through Video Conference on May 19, 2022 at 06:30 P.M. via Zoom with CA Ashutosh Agrawal from NB India Private Limited. The discussion was mainly about the ordinary course of business of the Company and about the industry and was not involving any Unpublished Price Sensitive Information (UPSI) Kindly take the same on your Records.
pdf
logo
Fredun Pharmaceuticals Ltd.
25 Dec 2021
653.80
1.35%
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
This is in reference to the Analyst Meet via Zoom Platform that was scheduled on December 25, 2021 at 4:00 P.M. We would like to share with stakeholders that a great response was received from the Anlaysts/Investors towards this Meeting. Questions in regards to procurement, capacity building, marketing, short term / long term debts of the Company, expenditure on R&D, Stock Management, tax burden & GST, new upcoming projects, cash credit and cash management, working capital requirements, Human Resources / workforce planning, factoring, overall Industry growth prospects were some of the aspects on which Anlaysts/Investors had raised their queries. Mr. Fredun Medhora, Managing Director of the Company addressed all these queries; as raised by the various Investors to their satisfaction. The Conference call started as scheduled at 4:00 P.M. and concluded at 6.25 P.M. No unpublished price sensitive information (UPSI) was discussed during the interactions in the said Zoom Meeting.
pdf
logo
Fredun Pharmaceuticals Ltd.
25 Dec 2021
653.80
1.35%
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
This is in reference to the Analyst Meet via Zoom Platform that was scheduled on December 25, 2021 at 4:00 P.M. We would like to share with stakeholders that a great response was received from the Anlaysts/Investors towards this Meeting. Questions in regards to procurement, capacity building, marketing, short term / long term debts of the Company, expenditure on R&D, Stock Management, tax burden & GST, new upcoming projects, cash credit and cash management, working capital requirements, Human Resources / workforce planning, factoring, overall Industry growth prospects were some of the aspects on which Anlaysts/Investors had raised their queries. Mr. Fredun Medhora, Managing Director of the Company addressed all these queries; as raised by the various Investors to their satisfaction. The Conference call started as scheduled at 4:00 P.M. and concluded at 6.25 P.M. No unpublished price sensitive information (UPSI) was discussed during the interactions in the said Zoom Meeting.
pdf
logo
Fredun Pharmaceuticals Ltd.
24 Dec 2021
653.80
1.35%
pdf
logo
Fredun Pharmaceuticals Ltd.
24 Dec 2021
653.80
1.35%
pdf

Earnings Calls Podcast on